All lobbying filings

Tiber Creek Group

Tiber Creek Group filed a registration amendment for Abbvie Inc. on October 8, 2026.

Lobbying for Abbvie Inc. · Global biopharmaceutical company.

As filed: TIBER CREEK GROUP for ABBVIE INC.

All filings by Tiber Creek Group · Everything Abbvie Inc. has reported

Filing · LD-1 registration Registration amendment

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 8, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Illinois

Official filing document

Lobbyists on this filing 3

COREY MALMGREN New on this filing

Previously held: Sen. Bill Nelson, Deputy Legislative Director & Health Counsel (2015-2018); Rep. Sandy Levin, Legislative Counsel (2013-2015), Legislative Correspondent, Staff Assistant (2008-2009); House Committee on Ways and Means, Legal Clerk/Intern (2010).
JONATHON JONES New on this filing

Previously held: Chief of Staff, Sen. Tom Carper (2001-2006).
DANIEL HOWARD ZAWITOSKI New on this filing

Previously held: Chief of Staff, Rep. Scott Peters (2018-2023); Legislative Director, Rep. Scott Peters (2015-2018); Legislative Assistant, Rep. Scott Peters (2014-2015); Legislative Correspondent, Rep. Scott Peters (2013-2014).

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 2

Medicare/Medicaid

Issues related to reimbursement of medications under Medicare Part B, including H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act.

Health Issues

Issues related to reimbursement of medications under Medicare Part B, including H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act.

Bills named in this filing 1

H.R. 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.